Streetbeat News

Stock Prices

URBN

BMO Capital has maintained its Market Perform rating for Urban Outfitters (NASDAQ:URBN) and raised its price target from $25.00 to $31.00. Shares of Urban Outfitters are trading up 16.17% over the last 24 hours, at $30.97 per share.

Portfolio Pulse from Benzinga Insights

May 24, 2023 | 5:00 pm

INTU

Piper Sandler has maintained its Overweight rating for Intuit (NASDAQ:INTU) but lowered its price target from $510.00 to $497.00. Intuit's shares are currently trading down 7.53% at $415.95.

Portfolio Pulse from Benzinga Insights

May 24, 2023 | 5:00 pm

AMZN

EQT

UBER

UNH

CNBC's Halftime Report discussed final trades, mentioning UnitedHealth Group, EQT, Amazon, and Uber Technologies as stocks to watch.

Portfolio Pulse from Happy Mohamed

May 24, 2023 | 5:00 pm

BUD

TAP

Bud Light is facing backlash over its promotion with transgender influencer Dylan Mulvaney, resulting in a 25% drop in sales and increased demand for rival beers like Coors Light and Miller Lite. Molson Coors, the parent company of Coors Light and Miller Lite, may face supply shortages due to the increased demand.

Portfolio Pulse from Happy Mohamed

May 24, 2023 | 4:56 pm

RFIL

RF Industries reported preliminary Q2 unaudited financial results, leading to a surge in its share prices.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 4:54 pm

IMMP

Immutep Limited shares are trading higher following the announcement of new clinical data from the triple combination therapy in the INSIGHT-003 trial.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 4:54 pm

PALI

Palisade Bio announced that it has received a European patent for 'Stable Neural Stem Cells Comprising An Exogenous Polynucleotide Coding For A Growth Factor And Methods Of Use Thereof'. This has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 4:53 pm

IMMP

Immutep Limited (NASDAQ: IMMP) announced positive data from the INSIGHT-003 Phase I trial of eftilagimod alpha triple combination therapy for 1st line non-small cell lung cancer. The therapy showed a 67% overall response rate and 91% disease control rate, outperforming previous results from a registrational trial.

Portfolio Pulse from Vandana Singh

May 24, 2023 | 4:50 pm

QCOM

QTEK

VFL

On Wednesday, 129 stocks hit new 52-week lows, with Qualcomm being the largest company by market cap to set a new low. QualTek Services' stock fell the most, down 38.7%, while Delaware Investments saw the sharpest rebound, with shares ascending 0.02%.

Portfolio Pulse from Benzinga Insights

May 24, 2023 | 4:49 pm

HSAI

Hesai Group reported Q1 financial results, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 4:48 pm